Scalable HPC & AI Infrastructure for COVID-19 Therapeutics

被引:5
作者
Lee, Hyungro [1 ]
Merzky, Andre [1 ]
Tan, Li [2 ]
Titov, Mikhail [1 ]
Turilli, Matteo [1 ]
Alfe, Dario [3 ]
Bhati, Agastya [3 ]
Brace, Alex [4 ]
Clyde, Austin [5 ]
Coveney, Peter [3 ]
Ma, Heng [4 ]
Ramanathan, Arvind [4 ]
Stevens, Rick [5 ]
Trifan, Anda [6 ]
Van Dam, Hubertus [2 ]
Wan, Shunzhou [3 ]
Wilkinson, Sean [7 ]
Jha, Shantenu [1 ,2 ]
机构
[1] Rutgers State Univ, Piscataway, NJ 08854 USA
[2] Brookhaven Natl Lab, Upton, NY 11973 USA
[3] UCL, London, England
[4] Argonne Natl Lab, Lemont, IL USA
[5] Univ Chicago, Chicago, IL 60637 USA
[6] Univ Illinois, Champaign, IL USA
[7] Oak Ridge Natl Lab, Knoxville, TN USA
来源
PROCEEDINGS OF THE PLATFORM FOR ADVANCED SCIENTIFIC COMPUTING CONFERENCE (PASC '21) | 2021年
基金
欧盟地平线“2020”; 美国能源部;
关键词
high-performance computing; machine learning; workflows; docking molecular dynamics; free energy estimation; COVID-19; FREE-ENERGY; PREDICTION;
D O I
10.1145/3468267.3470573
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
COVID-19 has claimed more than 2.7 x 10(6) lives and resulted in over 124 x 10(6) infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. We discuss innovations in computational infrastructure and methods that are accelerating and advancing drug design. Specifically, we describe several methods that integrate artificial intelligence and simulation-based approaches, and the design of computational infrastructure to support these methods at scale. We discuss their implementation, characterize their performance, and highlight science advances that these capabilities have enabled.
引用
收藏
页数:13
相关论文
共 50 条
[21]   Can AI help in the fight against COVID-19? [J].
Scott, Ian A. ;
Coiera, Enrico W. .
MEDICAL JOURNAL OF AUSTRALIA, 2020, 213 (10) :439-+
[22]   A Study on AI-based Waste Management Strategies for the COVID-19 Pandemic [J].
Rubab, Saddaf ;
Khan, Malik M. ;
Uddin, Fahim ;
Bangash, Yawar Abbas ;
Taqvi, Syed Ali Ammar .
CHEMBIOENG REVIEWS, 2022, 9 (02) :212-226
[23]   COVID-19: potential therapeutics for pediatric patients [J].
Nour K. Younis ;
Rana O. Zareef ;
Ghina Fakhri ;
Fadi Bitar ;
Ali H. Eid ;
Mariam Arabi .
Pharmacological Reports, 2021, 73 :1520-1538
[24]   COVID-19: A review of therapeutics under investigation [J].
Crosby, James C. ;
Heimann, Matthew A. ;
Burleson, Samuel L. ;
Anzalone, Brendan C. ;
Swanson, Jonathan F. ;
Wallace, Douglas W. ;
Greene, Christopher J. .
JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2020, 1 (03) :231-237
[25]   Exosome therapeutics for COVID-19 and respiratory viruses [J].
Popowski, Kristen D. ;
Dinh, Phuong-Uyen C. ;
George, Arianna ;
Lutz, Halle ;
Cheng, Ke .
VIEW, 2021, 2 (03)
[26]   Cardiovascular system and COVID-19: manifestations and therapeutics [J].
Mahenthiran, Ajay K. ;
Mahenthiran, Ashorne K. ;
Mahenthiran, Jo .
REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (03) :399-409
[27]   Vaccines and therapeutics for immunocompromised patients with COVID-19 [J].
Shoham, Shmuel ;
Batista, Carolina ;
Ben Amor, Yanis ;
Ergonul, Onder ;
Hassanain, Mazen ;
Hotez, Peter ;
Kang, Gagandeep ;
Kim, Jerome H. ;
Lall, Bhavna ;
Larson, Heidi J. ;
Naniche, Denise ;
Sheahan, Timothy ;
Strub-Wourgaft, Nathalie ;
Sow, Samba O. ;
Wilder-Smith, Annelies ;
Yadav, Prashant ;
Bottazzi, Maria Elena .
ECLINICALMEDICINE, 2023, 59
[28]   Current Effective Therapeutics in Management of COVID-19 [J].
Atluri, Kavya ;
Aimlin, Iris ;
Arora, Shitij .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
[29]   The Potential of Antiviral Peptides as COVID-19 Therapeutics [J].
Mahendran, Arun Suria Karnan ;
Lim, Yin Sze ;
Fang, Chee-Mun ;
Loh, Hwei-San ;
Le, Cheng Foh .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[30]   COVID-19: Clinical aspects and therapeutics responses [J].
Khan, Suliman ;
Ali, Ashaq ;
Shi, Hongwei ;
Siddique, Rabeea ;
Shabana ;
Nabi, Ghulam ;
Hu, Junjie ;
Wang, Tiejun ;
Dong, Men ;
Zaman, Wajid ;
Han, Guang .
SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (08) :1004-1008